Michael Pearson’s ‘price gouging’ strategy is focus of two state investigations
Activist hedge fund investor William Ackman appointed to boardThe chief executive of Valeant resigned on Monday,after the embattled Canadian drugmaker admitted that “improper conduct” by senior management caused the company to misstate its financial results.
Michael Pearson, who had returned to the helm final week after more than two months’ sick leave with pneumonia, and said he regretted the controversies the company has caused and will leave as soon as a successor is found. Continue reading...
Source: theguardian.com